PureTech Health plc
PTCHF · OTCMCIK 1782999fmd_1TVH2TD95ZHHTAFZ9MXB3FJND5Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2018 to Dec 31, 2025, 10 periods
| Line item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|---|
| Total revenues | 21 | 10 | 12 | 17 | 16 | 3 | 5 |
| Research and development | 77 | 86 | 82 | 110 | 152 | 96 | 69 |
| Operating income | (104) | (135) | (120) | (150) | (198) | (146) | (136) |
| Interest expense | (0) | 3 | 3 | 5 | 4 | 3 | 2 |
| Income before taxes | (68) | 478 | 19 | (59) | (93) | (36) | 24 |
| Income tax expense | 2 | 112 | 14 | 4 | (56) | 31 | (4) |
| Net income from continuing operations | (71) | 366 | 5 | (63) | (37) | (67) | 28 |
| Net income | (44) | 421 | 6 | (61) | (50) | (66) | 54 |
| Net income to common shareholders | – | – | – | (61) | (50) | (66) | 54 |